| Cardiac Imaging and Diagnostics | Lifetime | 221 | CA 7 | 99.61 |
| Lipoproteins and Cardiovascular Health | Lifetime | 100 | CA 6 | 99.41 |
| Heart Rate Variability and Autonomic Control | Lifetime | 243 | CA 10 | 98.96 |
| Coronary Interventions and Diagnostics | Lifetime | 203 | CA 5 | 99.32 |
| Heart rate and cardiovascular health | Lifetime | 12 | CA 1 | 98.84 |
| Cardiovascular Function and Risk Factors | Lifetime | 598 | CA 30 | 98.95 |
| Cardiovascular Issues in Pregnancy | Lifetime | 240 | CA 20 | 97.80 |
| Inflammasome and immune disorders | Lifetime | 267 | CA 9 | 97.36 |
| Acute Myocardial Infarction Research | Lifetime | 508 | CA 31 | 98.46 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 423 | CA 16 | 97.17 |
| Blood Pressure and Hypertension Studies | Lifetime | 786 | CA 33 | 97.86 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 645 | CA 32 | 97.95 |
| Heart Failure Treatment and Management | Lifetime | 849 | CA 52 | 97.15 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 884 | CA 32 | 96.56 |
| Cardiovascular Disease and Adiposity | Lifetime | 894 | CA 27 | 95.90 |
| Antioxidant Activity and Oxidative Stress | Lifetime | 728 | CA 21 | 96.02 |
| Cardiac Fibrosis and Remodeling | Lifetime | 523 | CA 22 | 93.59 |
| Inflammasome and immune disorders | 2021-2025 | 101 | CA 1 | 95.57 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 275 | CA 16 | 94.52 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 882 | CA 14 | 94.63 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 230 | CA 9 | 90.16 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 395 | CA 12 | 91.70 |
| Heart Failure Treatment and Management | 2021-2025 | 735 | CA 30 | 91.61 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 503 | CA 13 | 87.40 |
| Lipid metabolism and disorders | 2021-2025 | 244 | CA 13 | 81.65 |
| Fatty Acid Research and Health | 2021-2025 | 444 | CA 25 | 80.39 |
| Signaling Pathways in Disease | 2021-2025 | 293 | CA 7 | 68.23 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 931 | CA 14 | 61.68 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 810 | CA 18 | 53.29 |